STOCK TITAN

bioAffinity holder sells 41,529 shares, buys 17,873

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

bioAffinity Technologies, Inc. (BIAF) reported that 10% owner HRT Financial LP bought and sold common stock from September 22, 2026, through October 1, 2026. On October 1, HRT Financial LP purchased 17,873 shares at a weighted-average $6.5436 per share and sold 41,529 shares at a weighted-average $6.4466 per share. It also reported warrant purchases and sales; each warrant is exercisable for 1/450 of a common share at an exercise price of $3,645 per whole share. No Rule 10b5-1 plan is reported.

Insider HRT FINANCIAL LP
Role 10% Owner
Bought 138,248 shs ($1.04M)
Sold 162,228 shs ($1.18M)
Type Security Shares Price Value
Purchase Common Stock F26, F29 17,873 $6.5436 $117K
Sale Common Stock F27, F29 41,529 $6.4466 $268K
Purchase Common Stock F24, F28 12,125 $6.7775 $82K
Sale Common Stock F25, F28 20,432 $6.7638 $138K
Purchase Warrant (rights to buy) F22, F23 1 $0.32 $0.32
Purchase Common Stock F18, F23 8,894 $6.8647 $61K
Purchase Common Stock F19, F23 13,840 $7.1206 $99K
Sale Common Stock F20, F23 18,627 $6.8259 $127K
Sale Common Stock F21, F23 2,201 $7.0518 $16K
Purchase Warrant (rights to buy) F22, F23 2 $0.38 $0.76
Purchase Common Stock F15, F23 10,734 $7.6438 $82K
Purchase Common Stock F23 2 $8.09 $16.18
Sale Common Stock F16, F23 13,856 $7.5676 $105K
Sale Common Stock F17, F23 152 $8.1012 $1K
Sale Warrant (rights to buy) F13, F14 1 $0.26 $0.26
Purchase Common Stock F11, F14 7,271 $7.8065 $57K
Sale Common Stock F12, F14 9,111 $7.8588 $72K
Sale Warrant (rights to buy) F13, F14 6 $0.26 $1.56
Purchase Common Stock F9, F14 30,065 $7.668 $231K
Sale Common Stock F10, F14 27,246 $7.755 $211K
Purchase Warrant (rights to buy) F7, F8 1 $0.32 $0.32
Sale Warrant (rights to buy) F7, F8 2 $0.31 $0.62
Purchase Common Stock F3, F8 7,509 $7.9123 $59K
Purchase Common Stock F4, F8 11,002 $8.1438 $90K
Sale Common Stock F5, F8 11,129 $7.9399 $88K
Sale Common Stock F6, F8 10,859 $8.1074 $88K
Purchase Common Stock F1, F8 18,929 $8.5879 $163K
Sale Common Stock F2, F8 7,077 $8.6306 $61K
Holdings After Transaction: Warrant (rights to buy) — 6,699 warrants (Direct); Common Stock — 116,658 shares (Direct)
Holdings Before and After: Warrant (rights to buy), 6,704 to 6,699 warrants (Direct)
Footnotes (29)
  1. F1. Weighted average price; executed in multiple trades at prices from $8.405 to $8.74.*
  2. F2. Weighted average price; executed in multiple trades at prices from $8.405 to $8.74.*
  3. F3. Weighted average price; executed in multiple trades at prices from $7.78 to $7.995.*
  4. F4. Weighted average price; executed in multiple trades at prices from $8.00 to $8.80.*
  5. F5. Weighted average price; executed in multiple trades at prices from $7.86 to $7.99.*
  6. F6. Weighted average price; executed in multiple trades at prices from $8.00 to $8.84.*
  7. F7. Each warrant is exercisable for 1/450 of a share of Common Stock; the exercise price shown is per whole share, as adjusted for the issuer's reverse stock splits. Underlying amounts are rounded to four decimal places.
  8. F8. Represents the reporting person's beneficial ownership at the end of the transaction date, after all transactions on that date, including transactions not reported on this form.
  9. F9. Weighted average price; executed in multiple trades at prices from $7.50 to $7.95.*
  10. F10. Weighted average price; executed in multiple trades at prices from $7.59 to $7.98.*
  11. F11. Weighted average price; executed in multiple trades at prices from $7.67 to $7.95.*
  12. F12. Weighted average price; executed in multiple trades at prices from $7.74 to $7.96.*
  13. F13. Each warrant is exercisable for 1/450 of a share of Common Stock; the exercise price shown is per whole share, as adjusted for the issuer's reverse stock splits. Underlying amounts are rounded to four decimal places.
  14. F14. Represents the reporting person's beneficial ownership at the end of the transaction date, after all transactions on that date, including transactions not reported on this form.
  15. F15. Weighted average price; executed in multiple trades at prices from $7.33 to $7.93.*
  16. F16. Weighted average price; executed in multiple trades at prices from $7.33 to $7.92.*
  17. F17. Weighted average price; executed in multiple trades at prices from $8.10 to $8.13.*
  18. F18. Weighted average price; executed in multiple trades at prices from $6.68 to $6.99.*
  19. F19. Weighted average price; executed in multiple trades at prices from $7.01 to $7.50.*
  20. F20. Weighted average price; executed in multiple trades at prices from $6.69 to $6.99.*
  21. F21. Weighted average price; executed in multiple trades at prices from $7.00 to $7.60.*
  22. F22. Each warrant is exercisable for 1/450 of a share of Common Stock; the exercise price shown is per whole share, as adjusted for the issuer's reverse stock splits. Underlying amounts are rounded to four decimal places.
  23. F23. Represents the reporting person's beneficial ownership at the end of the transaction date, after all transactions on that date, including transactions not reported on this form.
  24. F24. Weighted average price; executed in multiple trades at prices from $6.56 to $6.99.*
  25. F25. Weighted average price; executed in multiple trades at prices from $6.59 to $6.99.*
  26. F26. Weighted average price; executed in multiple trades at prices from $6.23 to $6.88.*
  27. F27. Weighted average price; executed in multiple trades at prices from $6.07 to $6.865.*
  28. F28. Represents the reporting person's beneficial ownership at the end of the transaction date, after all transactions on that date, including transactions not reported on this form.
  29. F29. Represents the reporting person's beneficial ownership immediately after the transaction that reduced its beneficial ownership to 10% or less of the outstanding Common Stock, ending the period in which the transactions reported on this line occurred, including transactions not reported on this form.
Common-stock purchase 17,873 shares October 1, 2026; weighted-average purchase price was $6.5436 per share
Weighted-average purchase price $6.5436 per share HRT Financial LP common-stock purchase on October 1, 2026
Common-stock sale 41,529 shares October 1, 2026; weighted-average sale price was $6.4466 per share
Weighted-average sale price $6.4466 per share HRT Financial LP common-stock sale on October 1, 2026
Warrant exercise price $3,645 per whole share Price is adjusted for the issuer's reverse stock splits
Common shares per warrant 1/450 of a share Each warrant is exercisable for this amount of common stock
Warrant (rights to buy) technical
"Warrant (rights to buy)"
Weighted average price financial
"Weighted average price; executed in multiple trades at prices from $6.23 to $6.88."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial ownership financial
"beneficial ownership immediately after the transaction that reduced its beneficial ownership to 10% or less"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were HRT Financial LP's BIAF transactions on October 1?

On October 1, 2026, HRT Financial LP purchased 17,873 shares at a weighted-average $6.5436 per share and sold 41,529 shares at a weighted-average $6.4466 per share. No Rule 10b5-1 plan is reported.

What warrant transactions did HRT Financial LP report for BIAF?

Purchases were 1 warrant at a reported transaction price of $0.32 on September 23, 2 at $0.38 on September 28, and 1 at $0.32 on September 29; sales were 2 at $0.31 on September 23, 6 at $0.26 on September 24, and 1 at $0.26 on September 25. Each warrant is exercisable for 1/450 of a common share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HRT FINANCIAL LP

(Last)(First)(Middle)
3 WORLD TRADE CENTER, 175 GREENWICH STRE
76TH FLOOR

(Street)
NEW YORK NEW YORK 10007

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
bioAffinity Technologies, Inc. [ BIAF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/22/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/22/2026P18,929A$8.5879(1)126,519(8)D
Common Stock09/22/2026S7,077D$8.6306(2)126,519(8)D
Common Stock09/23/2026P7,509A$7.9123(3)128,884(8)D
Common Stock09/23/2026P11,002A$8.1438(4)128,884(8)D
Common Stock09/23/2026S11,129D$7.9399(5)128,884(8)D
Common Stock09/23/2026S10,859D$8.1074(6)128,884(8)D
Common Stock09/24/2026P30,065A$7.668(9)131,221(14)D
Common Stock09/24/2026S27,246D$7.755(10)131,221(14)D
Common Stock09/25/2026P7,271A$7.8065(11)126,037(14)D
Common Stock09/25/2026S9,111D$7.8588(12)126,037(14)D
Common Stock09/28/2026P10,734A$7.6438(15)127,533(23)D
Common Stock09/28/2026P2A$8.09127,533(23)D
Common Stock09/28/2026S13,856D$7.5676(16)127,533(23)D
Common Stock09/28/2026S152D$8.1012(17)127,533(23)D
Common Stock09/29/2026P8,894A$6.8647(18)134,741(23)D
Common Stock09/29/2026P13,840A$7.1206(19)134,741(23)D
Common Stock09/29/2026S18,627D$6.8259(20)134,741(23)D
Common Stock09/29/2026S2,201D$7.0518(21)134,741(23)D
Common Stock09/30/2026P12,125A$6.7775(24)126,146(28)D
Common Stock09/30/2026S20,432D$6.7638(25)126,146(28)D
Common Stock10/01/2026P17,873A$6.5436(26)116,658(29)D
Common Stock10/01/2026S41,529D$6.4466(27)116,658(29)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrant (rights to buy)$3,645(7)09/23/2026P106/22/202206/22/2027Common Stock0.0022$0.321,198(8)D
Warrant (rights to buy)$3,645(7)09/23/2026S206/22/202206/22/2027Common Stock0.0044$0.311,198(8)D
Warrant (rights to buy)$3,645(13)09/24/2026S606/22/202206/22/2027Common Stock0.0133$0.261,202(14)D
Warrant (rights to buy)$3,645(13)09/25/2026S106/22/202206/22/2027Common Stock0.0022$0.261,202(14)D
Warrant (rights to buy)$3,645(22)09/28/2026P206/22/202206/22/2027Common Stock0.0044$0.38913(23)D
Warrant (rights to buy)$3,645(22)09/29/2026P106/22/202206/22/2027Common Stock0.0022$0.32986(23)D
Explanation of Responses:
1. Weighted average price; executed in multiple trades at prices from $8.405 to $8.74.*
2. Weighted average price; executed in multiple trades at prices from $8.405 to $8.74.*
3. Weighted average price; executed in multiple trades at prices from $7.78 to $7.995.*
4. Weighted average price; executed in multiple trades at prices from $8.00 to $8.80.*
5. Weighted average price; executed in multiple trades at prices from $7.86 to $7.99.*
6. Weighted average price; executed in multiple trades at prices from $8.00 to $8.84.*
7. Each warrant is exercisable for 1/450 of a share of Common Stock; the exercise price shown is per whole share, as adjusted for the issuer's reverse stock splits. Underlying amounts are rounded to four decimal places.
8. Represents the reporting person's beneficial ownership at the end of the transaction date, after all transactions on that date, including transactions not reported on this form.
9. Weighted average price; executed in multiple trades at prices from $7.50 to $7.95.*
10. Weighted average price; executed in multiple trades at prices from $7.59 to $7.98.*
11. Weighted average price; executed in multiple trades at prices from $7.67 to $7.95.*
12. Weighted average price; executed in multiple trades at prices from $7.74 to $7.96.*
13. Each warrant is exercisable for 1/450 of a share of Common Stock; the exercise price shown is per whole share, as adjusted for the issuer's reverse stock splits. Underlying amounts are rounded to four decimal places.
14. Represents the reporting person's beneficial ownership at the end of the transaction date, after all transactions on that date, including transactions not reported on this form.
15. Weighted average price; executed in multiple trades at prices from $7.33 to $7.93.*
16. Weighted average price; executed in multiple trades at prices from $7.33 to $7.92.*
17. Weighted average price; executed in multiple trades at prices from $8.10 to $8.13.*
18. Weighted average price; executed in multiple trades at prices from $6.68 to $6.99.*
19. Weighted average price; executed in multiple trades at prices from $7.01 to $7.50.*
20. Weighted average price; executed in multiple trades at prices from $6.69 to $6.99.*
21. Weighted average price; executed in multiple trades at prices from $7.00 to $7.60.*
22. Each warrant is exercisable for 1/450 of a share of Common Stock; the exercise price shown is per whole share, as adjusted for the issuer's reverse stock splits. Underlying amounts are rounded to four decimal places.
23. Represents the reporting person's beneficial ownership at the end of the transaction date, after all transactions on that date, including transactions not reported on this form.
24. Weighted average price; executed in multiple trades at prices from $6.56 to $6.99.*
25. Weighted average price; executed in multiple trades at prices from $6.59 to $6.99.*
26. Weighted average price; executed in multiple trades at prices from $6.23 to $6.88.*
27. Weighted average price; executed in multiple trades at prices from $6.07 to $6.865.*
28. Represents the reporting person's beneficial ownership at the end of the transaction date, after all transactions on that date, including transactions not reported on this form.
29. Represents the reporting person's beneficial ownership immediately after the transaction that reduced its beneficial ownership to 10% or less of the outstanding Common Stock, ending the period in which the transactions reported on this line occurred, including transactions not reported on this form.
Remarks:
*The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
Adam Nunes11/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading